Luken Investment Analytics’s MetLife MET Stock Holding History

Luken Investment Analytics’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10	Closed	-$789	–	310
2025 Q4	$789	Buy	+10	New	+$791	﹤0.01%	268

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Luken Investment Analytics's MET Position: Q1 2026 in Review

Luken Investment Analytics sold out of MetLife (MET) in Q1 2026, closing a stake of 10 shares — an estimated $789 sold.

Luken Investment Analytics first reported a position in MET in Q4 2025 and held it in 1 quarter. The position peaked at $789 in Q4 2025. 1,384 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Luken Investment Analytics reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
Luken Investment Analytics sold 10 MetLife shares in Q1 2026, an estimated $789.
Luken Investment Analytics first reported a position in MetLife in Q4 2025 and held it in 1 quarter.
Luken Investment Analytics's MetLife position peaked at $789 in Q4 2025.
1,384 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Luken Investment Analytics's 13F filing for Q1 2026, filed 12 May 2026.